Maria Inmaculada Heras Fernando-rekin lankidetzan egindako argitalpenak (20)

2024

  1. The whole is greater than the sum of its parts: Long-read sequencing for solving clinical problems in haematology

    Journal of Cellular and Molecular Medicine, Vol. 28, Núm. 3

2018

  1. An early increase of CD56 bright natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease

    Transfusion, Vol. 58, Núm. 12, pp. 2924-2932

  2. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation

    Hematology, Vol. 23, Núm. 9, pp. 712-718

  3. Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution

    Blood Transfusion, Vol. 16, Núm. 3, pp. 273-278

2016

  1. Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: Kinetics, clinical impact and absence of STAT3 mutations

    British Journal of Haematology, Vol. 172, Núm. 6, pp. 937-946

2012

  1. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT)

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 17, Núm. 1

2008

  1. Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies

    Haematologica

2006

  1. L-asparaginase-induced antithrombin type I deficiency: Implications for conformational diseases

    American Journal of Pathology, Vol. 169, Núm. 1, pp. 142-153

1999

  1. Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer

    Bone Marrow Transplantation, Vol. 23, Núm. 6, pp. 621-624

  2. Preleukapheresis peripheral blood CD34+ cells predict progenitor cell collection yield and the necessary number of procedures to undergo [2]

    Haematologica

1998

  1. Bone marrow steady-state CD34+/CD71- cell content is a predictive value of rG-CSF-mobilized CD34+ cells

    Bone Marrow Transplantation, Vol. 21, Núm. 10, pp. 983-985

1997

  1. Differences in phycoerythrin- or fluorescein-isothiocyanate conjugated 8G12 on CD34+ cell evaluation

    Haematologica, Vol. 82, Núm. 3, pp. 334-335

  2. Disseminated aspergillosis after mobilization with intensive chemotherapy prior to autologous stem-cell transplant in chronic myeloid leukemia [1]

    American Journal of Hematology

  3. Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells

    British Journal of Haematology, Vol. 96, Núm. 2, pp. 418-420

  4. The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease

    British Journal of Haematology, Vol. 99, Núm. 2, pp. 304-307

  5. Trasplante autólogo con esquema BEAM en linfoma

    Sangre, Vol. 42, Núm. SUPPL. 1, pp. 46-49

1996

  1. Coste económico del autotrasplante de progenitores hematopoyéticos

    Medicina Clinica, Vol. 106, Núm. 9, pp. 329-332

  2. Immune recovery after autologous or rhG-CSF primed PBSC transplantation

    European Journal of Haematology, Vol. 56, Núm. 5, pp. 301-307

1995

  1. Effect of rhG-CSF on the mobilization of CD38 and HLA-DR subfractions of CD34+ peripheral blood progenitor cells

    Annals of Hematology, Vol. 71, Núm. 3, pp. 105-110

  2. The follow-up of the mobilization of circulating hematopoietic progenitor cells by granulocyte growth factor (G-CSF) using flow cytometry

    Medicina clínica, Vol. 104, Núm. 2, pp. 41-44